Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abetted, adult, aided, Alabama, altogether, APP, Arizona, biopharmaceutical, biotechnology, borrowing, brand, breached, ceasing, CHMP, comparison, confirmed, consideration, contemplated, cow, customary, dairy, Dakota, downgrade, EDNY, enabled, exploring, failed, Fee, fiduciary, firm, goal, hand, Hawaii, hearing, hypertension, ImClone, Island, knowingly, Lafayette, Maryland, Medicinal, metastatic, mission, Missouri, Monsanto, NAACP, Nebraska, Nevada, NSCLC, Ohio, Oklahoma, oncolytic, order, Oregon, PAH, Parenteral, Posilac, Princeton, proven, pulmonary, purportedly, pursue, recommending, resolve, revolving, Rhode, short, sometribove, spanning, stabilized, successfully, suspended, tadalafil, tender, tendered, Tennessee, Tippecanoe, Transnational, twelve, unchanged, upfront, Vermont, weakening, Wisconsin, wrongdoing, ZypadheraTM
Filing tables
Filing exhibits
Related press release
LLY similar filings
Filing view
External links
EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(Unaudited)
Eli Lilly and Company and Subsidiaries
(Dollars in millions)
(Dollars in millions)
Nine Months | ||||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
September 30, | Years Ended December 31, | |||||||||||||||||||||||
2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||||||||||||||||||
Consolidated pretax income before cumulative effect of a change in accounting principle | $ | 2,029.8 | $ | 3,876.8 | $ | 3,418.0 | $ | 2,717.5 | $ | 2,941.9 | $ | 3,261.7 | ||||||||||||
Interest1 | 185.4 | 322.5 | 344.8 | 245.7 | 162.9 | 121.9 | ||||||||||||||||||
Less interest capitalized during the period | (39.0 | ) | (94.2 | ) | (106.7 | ) | (140.5 | ) | (111.3 | ) | (60.9 | ) | ||||||||||||
Earnings | $ | 2,176.2 | $ | 4,105.1 | $ | 3,656.1 | $ | 2,822.7 | $ | 2,993.5 | $ | 3,322.7 | ||||||||||||
Fixed charges | $ | 185.4 | $ | 322.5 | $ | 344.8 | $ | 245.7 | $ | 162.9 | $ | 121.9 | ||||||||||||
Ratio of earnings to fixed charges | 11.7 | 12.7 | 10.6 | 11.5 | 18.4 | 27.3 | ||||||||||||||||||
1 | Interest is based upon interest expense reported as such in the consolidated income statement and does not include any interest related to unrecognized tax benefits, which is included in income tax expense. |